Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: A randomized controlled trial

JAMA

Volumn 285, Issue 18, 2001, Pages 2347-2354

  Audet, M C ^a   Moreau, M ^a   Koltun, W D ^a   Waldbaum, A S ^a   Shangold, G ^a   Fisher, A C ^a   Creasy, G W ^a  

^a R W JOHNSON PHARMACEUTICAL RES I   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORELGESTROMIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTACT ALLERGY; CONTRACEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSMENORRHEA; FEMALE; HUMAN; HUMAN EXPERIMENT; MASTALGIA; MENSTRUAL CYCLE; NORMAL HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE;

EID: 0035832318     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.285.18.2347     Document Type: Article

References (23)

1. Current reversible contraceptive methods: A global perspective
2. Trends in contraceptive use in the United States: 1982-1995
3. The pill: Combined oral contraceptives
4. Contraceptive failure, method-related discontinuation and resumption of use: Results from the 1995 National Survey of Family Growth
5. Contraceptive failure rates; new estimates from the 1995 National Survey of Family Growth
6. Compliance, counseling and satisfaction with oral contraceptives: A prospective evaluation
7. Use and misuse of oral contraceptives: Risk indicators for poor pill taking and discontinuation
8. Measuring compliance among oral contraceptive users
9. Bioavailability of 17-deacetylnorgestimate (17D-NGM) and ethinyl estradiol (EE) from a contraceptive patch
10. Dose proportionality study of a contraceptive patch
11. Pharmacokinetics of a contraceptive patch
12. Pharmacokinetics of a contraceptive patch at 4 application sites
13. Pharmacokinetics of multiple applications of a contraceptive patch
14. The essentials of contraception: Efficacy, safety, and personal considerations
15. Patient adherence with the contraceptive patch dosing schedule versus oral contraceptives
16. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception
17. Contraception: A clinical review for the internist
18. Lack of phototoxicity and photoallergy with a contraceptive patch
19. Evaluation of skin irritation in humans from a contraceptive patch
20. Effect of a contraceptive patch vs. placebo (PBO) on serum lipid profile